January 21, 2022 Comments Off on New patent for Amgen Inc drug OTEZLA Posted in: Patent Added Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from three suppliers. There are eleven patents…
The post New patent for Amgen Inc drug OTEZLA appeared first on DrugPatentWatch…
January 21, 2022 Comments Off on New patent for Gw Res drug EPIDIOLEX Posted in: Patent Added Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty…
The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch – M…
